None listed
Conditions
Brief summary
Elective and non-elective caesarean section (CS) rates have been increasing in Australia over the past 20 years. Increasing antenatal morbidity, has meant that surgical site infection (SSI) post CS is an important issue effecting Australian women. Populations most impacted include low socioeconomic and regional communities where high rates of antenatal comorbidity augment the incidence of SSI. Despite a recent trend towards supporting the development of evidence based bundled approaches to SSI reduction, there remains paucity in data proving efficacy and supporting bundle implementation. This study aimed to develop, implement and assess an evidence based caesarean infection prevention “CIP” bundled intervention to reduce SSI rates following CS in a high risk rural population. The study is a pre-post intervention study with 3 phases and included all women undergoing CS at a regional referral hospital between December 1st 2016 and December 31st 2018. A 12 month retrospective pre-intervention review identified all women who developed a post CS SSI. A comprehensive literature review informed the development of the intervention, which was implementation in December 2017. Prospective data collection for a subsequent 12 month period was collected on all women who underwent CS with pre and post comparative data analysis.
Interventions
The intervention is comprised of a caesarean infection prevention "CIP" bundle that was developed and implemented across the study population. The CIP bundle had five elements including: 1) Identification of women at risk of surgical site infection (SSI) post caesarean section (CS) - Antenatal identification and education administered by booking midwives and medical officers 2) Pre-operative site skin preparation protocol - No shaving, clipping if required in the operating theatre by the medical officer - Neutral detergent bed bath prior to CS administered by the attending midwife 3) Antibiotics prophylaxis administered pre-operatively - Cephazolin 2g Intravenously 15-60 minutes before knife to skin administered by Anaesthetics - Clindamycin 600mg Intravenously if known MRSA carrier or cephalosporin allergy 4) Operative site skin preparation - 2% Chlorhexidine gluconate and 70% alcohol for skin preparation - Applied by the attending medical officer or scrub nurse prior to surgical draping 5) Negative pressure wound therapy (NPWT) for Body Mass Index (BMI) > 35 - Applied intra-operatively and left on incision wound for 7 days - Women with BMI < 35 have standard wound dressings applied The intervention begins prior to surgery and concludes at the end of the surgical procedure or upon removal of negative pressure dressings at day 7 for women with a BMI over 35. Participants are followed up until 30 days post operatively. The intervention is the responsibility of all clinical midwives, obstetric medical staff, anaesthetics and the Infection Control Clinical Nurse Consultant (CNC). Surveillance and adherence data is collected using a multifaceted process including review of all patients undergoing CS in the study period, emergency department encounters and hospital admissions for wound complications within a 30 day post operative period.
Sponsors
Study design
Eligibility
Inclusion criteria
All women undergoing CS 12 months prior to implementation of the Bundle and all women undergoing CS 12 months post implementation of the bundle
Exclusion criteria
There are no exclusion criteria in this study